Molecular diagnostics firm ChromaCode nets $28 mln Series C
ChromaCode Inc, a molecular diagnostics company, has secured $28 million in Series C financing.
ChromaCode Inc, a molecular diagnostics company, has secured $28 million in Series C financing.
Copyright PEI Media
Not for publication, email or dissemination